[ad_1]
The ideal situation that specialists imagined would not occur: loss of cases of covid, start of the campaign vaccination and an economy which is reactivating little by little after the stocks imposed since March by the government. Imbalances in the policy for dealing with the pandemic, management issues and, most importantly, verbal incontinence to deliver information that has not materialized threaten this scenario.
Management of vaccine this was done in reverse of what is recommended. First it came in the ad, then the rest. And in the middle, he fell. Now the national government is desperately looking for a way to get someone a dose before December 31, a symbolic event more akin to propaganda than a health strategy. All despite the fact that Argentina has a history virtuous concerning vaccination and that certain specialists have focused on the country to develop part of the products or even carry out trials. This is not the first time that laboratories have liked Pfizer they are doing tests in Argentina. This time it was bigger and more important.
In 2006, for example, Mendoza was the scene of a successful trial: more than 4,500 babies were vaccinated for the first time in the world against him rotavirus, a pathogen that was the leading cause of hospitalization (due to gastroenteritis and diarrhea) in children. The trial was surrounded by some controversy, but it was successful: the vaccine was developed, then it was put on the schedule, and health improved. Something similar has happened with Pfizer regarding the coronavirus, but with a different ending for now. In Argentina, people believe in vaccinations; the degree of immunization is high. This is why there was a record of volunteers for the Pfizer process and why the world’s largest trial was carried out, with 5,700 people. But political and commercial management has failed and this product, one of the few internationally approved, is still not applied.
The president’s bold words about the vaccination campaign that will begin in December are worthless. The problem is not their word, but the consequences they can have on the expectations of the population and its credibility. Once again: in Argentina, the citizen trusts; but every effort has been made to distort the messages by putting political anxiety ahead of health management. Sputnik V is the only vaccine that will arrive immediately. This vaccine has been distributed in a few countries. But the greatest hope lies in the production of the vaccine Oxford and Astra Zeneca, on which Argentina has commitments for its distribution in the country. Approval could come before the end of the year, but the massive application wouldn’t happen until February.
Immunity
The decrease in cases has not reached the lowest expected peak and some facts may suggest that the “second hello “ pre-announced by various specialists occur before. Mass events (from the wake of Maradona), the opening of mass travel and meetings could generate this, as has happened in the rest of the world. In MendozaFor example, all the health data is encouraging; from occupancy of intensive care beds to positivity (13%). But the R0 factor has started to rise above 1, with data showing that once again every positive person infects more than one person. The health difficulties are the lack of seeking care (fewer people go to the doctor) and isolation: the infected do not isolate themselves as recommended.
The governors watch and fear. In Mendoza, the vaccination operation is managed with the mayors (at the national level, the army will join), but there is a an attempt at logistics, not yet a vaccine. Rodolfo Suarez I tried to breastfeed because there are steps to buy vaccines. The health emergency prevents it because the Nation monopolizes the supplies and distributes them. But the province also has a problem of scale: quantity of doses and resources. No one sells Mendoza vaccines at “retail” and contracts are “for millions of doses”. Likewise, management is done (there are, for example, Brazilian states that have their own campaigns outside the control of the national government).
In a first batch in Mendoza, no more than 25,000 doses would arrive, a testimonial number if we take into account that for influenza vaccination the number of people “Forced” multiplies this number by 15. 15% of the population over 64 is the priority and just above the area that has been challenged the Sputnik vaccine to achieve.
Discursive and managerial stumbles over the vaccine limit credibility. Oddly enough, this is happening in a direction that has looked in parallel immunity, But judicial. The parallel agenda that the ruling party has nothing to do with the health emergency, but with legal emergencies. This is why the rumors of changes in Alberto Fernndez’s cabinet and the tension over “officials who do not work” or those who must “find another job”, according to Vice-President Cristina Fernndez de Kirchner.
In this shot, there are even versions that don’t seem crazy: the landing of the Mendoza Anabel Fernndez Sagasti in the management team of Alberto Fernndez. The senator from Mendoza has other plans, however, and Cristina has other plans for her: that she continue to be the eyes and the voice in the Senate, in the plans for judicial reform and in the “defense of the project”. Project which they call less the direction of Alberto than the plans started with Nstor Kirchner in 2003, accelerated by Cristina since 2007 and which they are now trying to merge with a party in power divided into three. The Justice it is an obsession in that sense.
.
[ad_2]
Source link